Isodiol International Inc Share Price Other OTC
Equities
CA46500L1013
Pharmaceuticals
Sales 2018 | 19.14M 1.51B | Sales 2019 | 22.25M 1.76B | Capitalization | 49.96M 3.94B |
---|---|---|---|---|---|
Net income 2018 | -36M -2.84B | Net income 2019 | -126M -9.94B | EV / Sales 2018 | 12.6 x |
Net cash position 2018 | 15.55M 1.23B | Net Debt 2019 | 5.22M 412M | EV / Sales 2019 | 2.48 x |
P/E ratio 2018 |
-4.94
x | P/E ratio 2019 |
-0.37
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Kevin Swadish
PRN | Corporate Officer/Principal | - | 13/02/19 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcos Agramont
CEO | Chief Executive Officer | - | 23/05/17 |
Director/Board Member | - | 29/08/18 | |
Director/Board Member | - | 20/11/18 |
1st Jan change | Capi. | |
---|---|---|
+45.15% | 6.34B | |
-14.00% | 4.61B | |
+9.54% | 3.39B | |
-8.99% | 3.29B | |
+50.03% | 2.02B | |
-6.97% | 1.73B | |
-0.31% | 1.67B | |
+50.00% | 1.63B | |
-10.61% | 1.59B |